Diastat and Hyperreflexia - a phase IV clinical study of FDA data

Summary:

Hyperreflexia is reported only by a few people who take Diastat.

The phase IV clinical study analyzes which people take Diastat and have Hyperreflexia. It is created by eHealthMe based on reports of 1,781 people who have side effects while taking Diastat from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 29, 2022

1,781 people reported to have side effects when taking Diastat.
Among them, 3 people (0.17%) have Hyperreflexia.

What is Diastat?

Diastat has active ingredients of diazepam. eHealthMe is studying from 1,791 Diastat users for its effectiveness, alternative drugs and more.

What is Hyperreflexia?

Hyperreflexia (overactive or over responsive reflexes) is found to be associated with 979 drugs and 619 conditions by eHealthMe.

Number of Diastat and Hyperreflexia reports submitted per year:

Gender of people who have Hyperreflexia when taking Diastat *:

female: 0.0 %
male: 100 %

Age of people who have Hyperreflexia when taking Diastat *:

Common drugs people take besides Diastat *:

Trileptal: 3 people, 100.00%
Lamictal: 3 people, 100.00%
Lacosamide: 3 people, 100.00%

Common side effects people have besides Hyperreflexia *:

Movement - Uncoordinated: 3 people, 100.00%
Hemiparesis (weakness on one side of the body): 3 people, 100.00%
Gait Disturbance: 3 people, 100.00%
Swelling Face: 2 people, 66.67%
Psychomotor Skills Impaired: 2 people, 66.67%
Clonus (series of involuntary, rhythmic, muscular contractions and relaxations): 2 people, 66.67%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 2 people, 66.67%
Drooling (drop saliva uncontrollably from the mouth): 2 people, 66.67%
Drowsiness: 2 people, 66.67%
Activities Of Daily Living Impaired: 2 people, 66.67%

Common conditions people have *:

Partial Seizures (seizures which affect only a part of the brain at onset): 3 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Diastat and have Hyperreflexia?

Check whether Hyperreflexia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Hyperreflexia and when was it recovered:

Hyperreflexia in Diastat

Expand to all the drugs that have ingredients of diazepam:

Hyperreflexia and drugs with ingredients of diazepam (76 reports)

Alternative drugs to, pros and cons of Diastat:

Diastat (1,791 reports)

Common Diastat side effects:

Browse all side effects of Diastat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Hyperreflexia treatments and more:

Hyperreflexia (4,257 reports)

COVID vaccines that are related to Hyperreflexia:

Common drugs associated with Hyperreflexia:

All the drugs that are associated with Hyperreflexia:

Hyperreflexia (979 drugs)

Common conditions associated with Hyperreflexia:

Depression: 518 reports
Multiple sclerosis: 173 reports
Pain: 149 reports
Bipolar disorder: 140 reports
High blood pressure: 107 reports

All the conditions that are associated with Hyperreflexia:

Hyperreflexia (619 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diazepam (the active ingredients of Diastat) and Diastat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.